4SC AG - Akt. nach Kapitalher

NEW
FRA:VSC (Germany)   Akt. nach Kapitalherabsetzung
€ 0.10 (0%) Jun 26
At Loss
P/B:
5.56
Market Cap:
€ 1.32M ($ 1.53M)
Enterprise V:
€ -4.11M ($ -4.76M)
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

4SC AG

ISIN : DE000A3E5C40

Share Class Description:

FRA:VSC: Akt. nach Kapitalherabsetzung

Total Employee Number:

11
Description
4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that can target key indications in cancer with high unmet medical needs. Its pipeline is protected by a comprehensive portfolio of patents and currently comprises two drug candidates in clinical development resminostat and Domatinostat. The geographic area of the company is Germany, the EU, and Other countries, and the majority of the revenue comes from Other Countries.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt
No Debt
Equity-to-Asset
0.01
Piotroski F-Score
6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-1.3
Distress
Grey
Safe
Beneish M-Score
-0.08
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
14-Day RSI
33.04
12-1 Month Momentum %
-83.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
1.04
Quick Ratio
1.04
Cash Ratio
1.01
Days Sales Outstanding
12.27
Days Payable
2592.85

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio
35.4

4SC AG Filings

Filing Date Document Date Form
No Filing Data

4SC AG Stock Events

Financials Calendars
Event Date Price (€)
0.2:1 Stock Split 2021-07-19 7.55 (+0.00%)
0.2:1 Stock Split 2015-04-27 28.92 (-6.04%)
Show
Entries

Press Release

Subject Date
No Press Release

Articles on 4SC AG

No articles.